Abstract:Introduction Donor hematopoietic stem cell (DHSC) infusions are increasingly being studied in transplant patients for tolerance induction. Methods To analyze the fate of infused DHSCs in patients, we developed an in vitro culture system utilizing CD34 + DHSCs stimulated with irradiated allogeneic cells in cytokine supplemented medium long-term. Results Flow cytometric analyses revealed loss of the CD34 marker and an increase in CD33 + myeloid and CD3 + T-cell proportion by 10.4% and 72.7%, respectively, after 21 days in culture. T-cells primarily expressed TcR-αβ and were of both CD4 + and CD8 + subsets. Approximately 80% of CD3 + T cells lacked expression of the co-stimulatory receptor CD28. The CD4 + compartment was predominated by CD4 + CD25 + CD127-FOXP3 + Tregs (>50% CD4 + CD127- compartment) with <1% of all leukocytes exhibiting a CD4 + CD127 + phenotype. Molecular analyses for T-cell receptor excision circles showed recent and increased numbers of TcR rearrangements in generated T cells over time suggesting de novo differentiation from DHSCs. CD33 + myeloid cells mostly expressed HLA-DR, but lacked expression of co-stimulatory receptors CD80 and CD83. When studied as modulators in primary mixed lymphocyte reactions where the cells used to stimulate the DHSC were used as responders, the DHSC-lines and their purified CD8 + , CD4 + , CD33 + and linage negative subsets inhibited the responses in a dose-dependent and non-specific fashion. The CD8 + cell-mediated inhibition was due to direct lysis of responder cells. Discussion Extrapolation of these results into the clinical situation would suggest that DHSC infusions into transplant recipients may generate multiple subsets of donor “chimeric” cells and promote recipient Treg development that could regulate the anti-donor immune response in the periphery. These studies have also indicated that T cell maturation can occur in vitro in response to allogeneic stimulation without the pre-requisite of a thymic-like environment or NOTCH signaling stimulatory cell line.

Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4+ regulatory T cells

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

T regulatory cells as an immunotherapy for transplantation.

T Regulatory Cells As an Immunotherapy for Transplantation

Efficient Induction and Expansion of Human Alloantigen-Specific Cd8 Regulatory T Cells from Naive Precursors by Cd40-Activated B Cells

Efficient Generation of Human Alloantigen-Specific CD4+ Regulatory T Cells from Naive Precursors by CD40-activated B Cells

Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells.

Efficient Induction and Expansion of Human Alloantigen-Specific CD8 Regulatory T Cells from Naive Precursors by CD40-Activated B Cells1

CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance.

Transfer of Regulatory T Cells Generated Ex Vivo Modifies Graft Rejection Through Induction of Tolerogenic CD4+CD25+ Cells in the Recipient

A Tolerogenic Semimature Dendritic Cells Induce Effector T-cell Hyporesponsiveness by Activation of Antigen-Specific CD4+CD25+ T Regulatory Cells That Promotes Skin Allograft Survival in Mice

In vivo induction of regulatory T cells by anti-CD45RB antibody causes transferable tolerance to discordant human xenogenic islets.

Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance

Antigen-Dependent Suppression of Alloresponses by Foxp3-Induced Regulatory T Cells in Transplantation

Ex Vivo Expansion of Human Tregs Specific for Alloantigens Presented Directly or Indirectly.

Induction of Allospecific Tolerance by Immature Dendritic Cells Genetically Modified to Express Soluble Tnf Receptor

Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells.

Induction of Antigen-Specific Immune Tolerance by TGF-beta-induced CD4+Foxp3+ Regulatory T Cells.

Differentiation of regulatory myeloid and T-cells from adult human hematopoietic stem cells after allogeneic stimulation

Promotion of Allograft Survival by CD4+CD25+ Regulatory T Cells: Evidence for in Vivo Inhibition of Effector Cell Proliferation

Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models.